Jeff is primarily responsible for sourcing investment opportunities, performing due diligence, negotiating and monitoring Life Science and Environmental Science portfolio investments.

Jeff joined Lighthouse in the first quarter of 2001, bringing over 10 years of commercial and technology lending experience. Most recently, Jeff spent over five years at Fleet Boston managing the commercial credit function, underwriting and evaluating lending and leasing opportunities, and monitoring portfolio performance. Prior to Fleet, Jeff served in various loan and credit analysis roles at The CIT Group and First Chicago National Bank in Chicago.

While at Lighthouse, Jeff has led investments at NeuroMetrix (NASDAQ: NURO), Alnylam Pharmaceuticals (NASDAQ: ALNY), AtriCure (NASDAQ: ATRC); CVRx, CombinatoRx (NASDAQ: CRXX), Concentric Medical, Restore Medical (NASDAQ: REST); Acorn Cardiovascular, Insulet (NASDAQ: PODD), SwissRay, Gevo, Stion Corporation, Codon Devices, LS9, Ausra and Kolis Scientific.

Jeff holds a BS in Business Economics and Finance from Ohio University, and an MBA from Loyola University Chicago.

jeff@lcpartners.com